Skip to main content

Jose Alejandro Luchsinger

NIH Rank #67
  • Top 1% Funded
  • R01 Holder
  • Multi-Institutional
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 6900624Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine

NIH Funding · FY2025

Linked Award Amount
$24.3M
Full award amounts, FY2025
Award Records
6
Records listing this PI
Award-Linked Rank
#67
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Jose Alejandro Luchsinger. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Jose Alejandro Luchsinger as a PI. Multi-PI records show the full award amount for context.

  • 5R01AG076634-03R01
    Phase II randomized controlled trial of benfotiamine in early Alzheimer's Disease
    $9.6M
    award amount
  • 5R01AG062624-05R01
    Metformin in Alzheimer's dementia Prevention (MAP)
    $6.5M
    award amount
  • 5R01AG058969-07R01
    Subclinical Vascular Contributions to Alzheimer's Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Multisite Study of AD (Renewal)
    $4.7M
    award amount
  • 5R01AG050440-10R01
    Diabetes and brain amyloid in middle aged Hispanics
    $3.4M
    award amount
  • 5K24AG045334-09K24
    Midcareer Award for Research in Dementia Risk Factors and Prevention
    $121.1K
    award amount
  • 5U19AG078558-04U19
    Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project
    $119.7K
    award amount

Award organizations

Organizations that administered FY2025 awards listing Jose Alejandro Luchsinger as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Columbia University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    Entered Top 50% Nationally
    Ranked #255
  8. 2024
    Entered Top 25% Nationally
    Ranked #255
  9. 2024
    Entered Top 10% Nationally
    Ranked #255
  10. 2024
    Entered Top 5% Nationally
    Ranked #255
  11. 2025
    $25M Cumulative Funding
  12. 2025
    Entered Top 1% Nationally
    Ranked #67
  13. 2025
    Multi-Institutional Research
    Awards at 3 institutions
  14. 2025
    R01 Grant Holder